Aetna Maintained at Outperform - Analyst Blog

By
A A A

We are reiterating our Outperform recommendation on the shares of Aetna Inc. ( AET ) following better-than-expected second quarter earnings results. Aetna second quarter earnings threw a 9.4% positive earnings surprise. Over the past four quarters this Zacks Rank #2 (Buy) health insurer has delivered an average positive surprise of 7.9%.

Why Reiteration?

On Jul 30, Aetna reported second-quarter 2013 earnings of $1.52 per share, surpassing the Zacks Consensus Estimate by 13 cents per share. Earnings also increased 16% year over year. The earnings upside came on the back of earnings accretion from Coventry acquisition, strong underlying performance in Commercial business and membership growth. 

Aetna has also been witnessing rising earnings estimates. Over the last 7 days, 6 out of 14 estimates moved north, pushing the Zacks Consensus Estimate for 2013 by 0.7% to $5.88. The same for 2014 rose 0.3% to $6.37 as 4 of 14 estimates were raised over the same time frame. The expected long term earnings growth is 11.9%. 

Aetna's business execution over the last few years has been excellent. While performance has been strong across the board a stand-out area is its organic and acquisition-fueled growth.

Aetna has made huge investment in technology upgradation.  

Aetna concluded the acquisition of Coventry in May. The acquisition enhances the company's Medicaid footprint, gives it more credibility, and better positions the company for the enormous Medicaid RFP expansion and dual growth opportunities. 

It has also made a number of acquisitions in its Commercial business over the past 2-3 years. At the same time, the company is witnessing an increase in membership

Aetna is aggressively forming Accountable Care Organizations to generate incremental revenues. We also have a growing optimism for international growth opportunities at Aetna.

A strong balance sheet with an efficient capital management program provides inherent strength. 

Other Stocks to Consider

Other players, Molina Healthcare, Inc. ( MOH ) , Health Net, Inc.  ( HNT ), WellPoint Inc. ( WLP ) all with Zacks Rank #2 (Buy) are worth considering.  



AETNA INC-NEW (AET): Free Stock Analysis Report

HEALTH NET INC (HNT): Free Stock Analysis Report

MOLINA HLTHCR (MOH): Free Stock Analysis Report

WELLPOINT INC (WLP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: AET , HNT , MOH , WLP

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Cheap Ways to Sleep Better
Cheap Ways to Sleep Better          

Stocks

Referenced

100%
100%
100%
80%

Most Active by Volume

105,679,298
  • $16.13 ▼ 0.19%
43,130,824
  • $101.32 ▲ 0.74%
24,108,376
  • $59.80 ▲ 7.34%
22,524,427
  • $26.15 ▼ 1.06%
22,194,114
  • $24.65 ▼ 0.96%
21,835,360
  • $99.05 ▲ 0.15%
20,872,575
  • $34.94 ▼ 0.60%
20,561,803
    $74.57 unch
As of 8/22/2014, 04:02 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com